Endocrine Flashcards

0
Q

Deficiency of growth hormone with or without a deficiency of other pituitary hormones

Congenital or acquired

Clinical manifestations:

  • of normal size and weight at birth
  • atrophy of adrenal cortex, sensitivity to cold, absence of sweating

PE findings:

  • tendency to hypoglycemia
  • short and broad face, prominent frontal bone, depressed nasal bridge, underdeveloped mandible, short neck, high-pitched voice, well proportioned extremities but small hands and feet, delayed sexual maturity

LABORATORY findings

  • diagnosis of classic type is suspected in cases of PROFOUND POSTNATAL GROWTH FAILURE (height >3 SD below the mean for age and gender)
  • definitive diagnosis: ABSENT or LOW LEVELS OF GH in response to stimulation
  • X-ray findings: destructive or space-occupying lesions: enlargement of the sella or erosions and calcifications within or above the sella turcica; delayed skeletal maturation
A

HYPOPITUITARISM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Normal range for height

Over time, it starts falling off the height curve

A

Pathologic short stature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Normal range for height

Normal final adult height is reached but the growth spurt and puberty are delayed

A

Constitutional short stature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Stay parallel to the growth curve

A

Familial short stature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Parallel to the growth curve but is much more marked

A

Prenatal short stature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Guidelines for growth hormone treatment

A

hGH 0.18.-0.3 mg/kg/wk SC in 6-7 divided doses

Criteria for stopping tx: growth rate 14 yrs in girls and >16 years in boys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Young persons with open epiphyses, overproduction of GH

A

Gigantism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Persons with closed epiphyses

A

Acromegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cardinal clinical feature of gigantism

A

Longitudinal growth acceleration due to GH excess

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Coarse facial features, enlarged hands and feet, broad noses, enlarged tongue, visual field defects

A

Hyperpituitarism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diagnosis:
Serum somatomedin C (IGF-1) is uniformly increased in untreated cases
- more precise and cost-effective than serum GH because GH levels fluctuate and have short serum half-life (22 minutes)

A

Hyperpituitarism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Management of Hyperpituitarism

A
  • if with well-circumscribed pituitary adenomas: transsphenoidal surgery (complete removal of the tumor)
  • pituitary radiation and medical therapy
  • somatostatin analog (Octreotide)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cardinal features of diabetes insipidus

A

Polyuria and polydipsia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

2 types of diabetes insipidus

A
  1. Vasopressin deficiency (central DI)

2. Vasopressin insensitivity (nephrogenic DI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pathogenesis of DIABETES INSIPIDUS

A

As plasma osmolality increases, pat it becomes thirsty and drinks fluids

Plasma is diluted before it reaches the higher set level to stimulate ADH release

Initiates cycle of polyuria and polydipsia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Congenital, trauma, tumors, autoimmune, infection, drugs (ethanol, phenytoin, etc)

Management:

  • Fluid therapy
  • Long-acting vasopressin analog dDAVP
A

Central diabetes insipidus

16
Q

Congenital (more severe), hypercalcemia, hypokalemia, renal disease (PCKD, CRF), drugs (lithium, amophotericin, rifampicin, etc)

Management:

  • Treat underlying disorder
  • thiazides (decrease urine flow to DCT, induce formation of functional receptors)
A

Nephrogenic diabetes insipidus

17
Q

What the hormone involved in Diabetes insipidus and what is its role?

A

VASOPRESSIN
- secreted from the posterior pituitary

Principal regulator of toxicity

Has both anitdiuretic and vascular pressor activity

Synthesized in the paracentricular and supraoptic nuclei of the hypothalamus

18
Q

Onset of secondary sexual characteristics before 8 years old in girls and 9 years old in boys

A

Precocious puberty

19
Q

Conditions causing precocious puberty

A
  1. Gonadotropin-dependent puberty (true precocious puberty) - increased sex hormone secretion
  2. Idiopathic
  3. Brain tumors, severe head trauma, hydrocephalus
  4. Prolonged and untreated hypothyroidism
  5. Ovarian tumors
20
Q

Breast development in the first 2 years of life, regress after 2 years and rarely progressive

A

Premature thelarche

21
Q

Pubic hair, early maturational event of adrenal androgen production

A

Premature adrenarche

22
Q

Pertinent lab findings:
- Immunometric assay for LH (serum) - serial blood samples obtained during sleep and shows pulsatile LH secretion

  • pelvic ultrasound - progressive enlargement of the ovaries and uterus
  • Cranial CT scan/cranial MRI - physiologic enlargement of the pituitary gland; pedunculated mass attached to the tuber cinereum of the floor of the 3rd ventricle
A

Precocious puberty

23
Q

Treatment of precocious puberty

A

Leuprolide acetate -0.25-0.3mg/kg IM once every 4 weeks (true precocious puberty)

If treatment is effective, serum sex hormones decrease to prepubertal levels (testosterone <1 IU/L